S100A8 and S100A9 in cancer

Y Chen, Y Ouyang, Z Li, X Wang, J Ma - Biochimica et Biophysica Acta …, 2023 - Elsevier
Abstract S100A8 and S100A9 are Ca 2+ binding proteins that belong to the S100 family.
Primarily expressed in neutrophils and monocytes, S100A8 and S100A9 play critical roles in …

S100 proteins in fatty liver disease and hepatocellular carcinoma

E Delangre, E Oppliger, S Berkcan… - International journal of …, 2022 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent and slow progressing hepatic
pathology characterized by different stages of increasing severity which can ultimately give …

Viral nanoparticle vaccines against S100A9 reduce lung tumor seeding and metastasis

YH Chung, OA Ortega-Rivera… - Proceedings of the …, 2023 - National Acad Sciences
Metastatic cancer accounts for 90% of all cancer-related deaths and continues to be one of
the toughest challenges in cancer treatment. A growing body of data indicates that S100A9 …

S100 calcium‐binding protein A9 from tumor‐associated macrophage enhances cancer stem cell‐like properties of hepatocellular carcinoma

R Wei, WW Zhu, GY Yu, X Wang, C Gao… - … Journal of Cancer, 2021 - Wiley Online Library
Tumor‐associated macrophages (TAMs) are crucial components of the tumor
microenvironment. They play vital roles in hepatocellular carcinoma (HCC) progression …

[HTML][HTML] High S100A9+ cell density predicts a poor prognosis in hepatocellular carcinoma patients after curative resection

J Liao, JZ Li, J Xu, Y Xu, WP Wen, L Zheng… - Aging (Albany NY …, 2021 - ncbi.nlm.nih.gov
S100A9 is differentially expressed in various cell types and is associated with the
development, progression and metastasis of various cancers. However, the expression …

Metastatic Colon Cancer Treatment Using S100A9-Targeted Cowpea Mosaic Virus Nanoparticles

YH Chung, BA Volckaert, NF Steinmetz - Biomacromolecules, 2022 - ACS Publications
Peritoneal metastases (PMs) occur due to the metastasis of gynecological and
gastrointestinal cancers such as ovarian, colon, pancreatic, or gastric tumors. PM outgrowth …

Establishment and evaluation of exosomes-related gene risk model in hepatocellular carcinoma

L Zhu, Y Lou, Q Xiao, L Wang, G Chen, W Yang… - Biochemical …, 2024 - Springer
Hepatocellular carcinoma (HCC) is a challenging disease to evaluate in terms of prognosis,
requiring close attention to the prognosis of HCC patients. Exosomes have been shown to …

Diagnosis biomarkers of cholangiocarcinoma in human bile: an evidence-based study

F Bao, J Liu, H Chen, L Miao, Z Xu, G Zhang - Cancers, 2022 - mdpi.com
Simple Summary A liquid biopsy has the characteristics of low trauma and easy acquisition
in the diagnosis of cholangiocarcinoma. Many researchers try to find diagnostic or …

Mechanistic research on the anti-hepatocellular carcinoma effect of kurarinone based on network pharmacology and experimental validation

P Jiang, Y Liang, X Cui, Y Zhang, C Peng… - European Journal of …, 2023 - Elsevier
Introduction Kurarinone is a potential natural compound with antitumour activity. The effect
and mechanism of kurarinone against hepatocellular carcinoma (HCC) remain unclear …

Role of the S100 protein family in liver disease

S Yao, X Yang, J An, H Jin… - International …, 2021 - spandidos-publications.com
Liver disease is a significant health challenge worldwide and comprises liver fibrosis and
cirrhosis, viral hepatitis, fatty liver, non‑alcoholic fatty liver disease, alcoholic liver disease …